Inhibitors of myelination: ECM changes, CSPGs and PTPs
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
After inflammation-induced demyelination, such as in the disease multiple sclerosis, endogenous remyelination often fails. However, in animal models of demyelination induced with toxins, remyelination can be quite robust. A significant difference between inflammation-induced and toxin-induced demyelination is the response of local cells within the lesion, including astrocytes, oligodendrocytes, microglia/macrophages, and NG2+ cells, which respond to inflammatory stimuli with increased extracellular matrix (ECM) protein and chondroitin sulfate proteoglycan (CSPG) production and deposition. Here, we summarize current knowledge of ECM changes in demyelinating lesions, as well as oligodendrocyte responses to aberrant ECM proteins and CSPGs after various types of demyelinating insults. The discovery that CSPGs act through the receptor protein tyrosine phosphatase sigma (PTPσ) and the Rho-ROCK pathway to inhibit oligodendrocyte process extension and myelination, but not oligodendrocyte differentiation (Pendleton et al., Experimental Neurology (2013) vol. 247, pp. 113-121), highlights the need to better understand the ECM changes that accompany demyelination and their influence on oligodendrocytes and effective remyelination.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chondroitinase ABC promotes functional recovery after spinal cord injury
Bradbury, E. J., Moon, L. D. F., Popat, R. J., King, V. R., Bennett, G. S., Patel, P. N., Fawcett, J. W., & McMahon, S. B. (2002) · Nature · doi:10.1038/416636a · Cited by 2,357 · cited 4×
“Multiple studies have demonstrated thebenefit of reducedCSPGaccumulation and signaling for both axonal regeneration and remyelination (Bradbury et al., 2002; Davies et al., 2004; Huang et al., 2006; KarimiAbdolrezaee et al., 2012; Siebert et al., 2011; Soleman et al., 2012; Starkey et al., 2012;…”
InfluentialFitch, M. T., & Silver, J. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2007.05.014 · Cited by 1,007 · cited 3×
“inhibitory to regeneration (Fitch and Silver, 2008; Galtrey et al., 2008; Morgenstern et al., 2002; Rhodes and Fawcett, 2004; Sherman and Back, 2008).”
Premyelinating Oligodendrocytes in Chronic Lesions of Multiple Sclerosis
Chang, A., Tourtellotte, W. W., Rudick, R., & Trapp, B. D. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa010994 · Cited by 991 · cited 1×
“It is unlikely that this inability to remyelinate results from an absence of OPCs in the adult CNS, as OPCs are present in elderly patients even after decades of disease (Chang et al., 2002, 2012).”
PTPσ Is a Receptor for Chondroitin Sulfate Proteoglycan, an Inhibitor of Neural Regeneration
Shen, Y., Tenney, A. P., Busch, S. A., Horn, K. P., Cuascut, F. X., Liu, K., He, Z., Silver, J., & Flanagan, J. G. (2009) · Science · doi:10.1126/science.1178310 · Cited by 682
Lecticans: organizers of the brain extracellular matrix
Yamaguchi, Y. (2000) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000690 · Cited by 642 · cited 3×
“…controls distribution and presentation of solublemolecules in the ECM (Bandtlow and Zimmermann, 2000 and others; Fitch and Silver, 1997; Sanes, 1989; Schaefer and Schaefer, 2010; Schwartz and Domowicz, 2004; Sirko et al., 2010; Yamaguchi, 2000; Zimmermann and Dours-Zimmermann, 2008 and others).”
Proteoglycans in the Developing Brain: New Conceptual Insights for Old Proteins
Bandtlow, C. E., & Zimmermann, D. R. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.4.1267 · Cited by 632
Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation
Back, S. A., Tuohy, T. M. F., Chen, H., Wallingford, N., Craig, A., Struve, J., Luo, N. L., Banine, F., Liu, Y., Chang, A., et al. (2005) · Nature Medicine · doi:10.1038/nm1279 · Cited by 612 · cited 3×
“Toxin-induced demyelination following lysolecithin injection into the spinal cord or corpus callosum, or ethidium bromide injection into the cerebellar peduncles results in minimal immune response and robust remyelination (Back et al., 2005; Franklin et al., 1991, 1996; Harrington et al., 2010; Kotter et al., 2001; Na…”
Davies, S. J. A., Goucher, D. R., Doller, C., & Silver, J. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-14-05810.1999 · Cited by 606 · cited 1×
“Introduction remyelination by oligodendrocytes (Davies et al., 1999; Fitch and A hallmark of central nervous system (CNS) injury is the activation and proliferation of local glial cells, including microglia, astrocytes, and oligodendrocytes.”
Galtrey, C. M., & Fawcett, J. W. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2006.09.006 · Cited by 575 · cited 5×
“Tenascins influence the reactivity of astrocytes, which are a major source of CSPGs after injury (Galtrey and Fawcett, 2007;Holley et al., 2005; Silver andMiller, 2004; Yiu andHe, 2006), suggesting that the spatiotemporal expression of tenascin-C and tenascin-R in lesions may be important…”
InfluentialNait‐Oumesmar, B., Decker, L., Lachapelle, F., Avellana‐Adalid, V., Bachelin, C., & Van Evercooren, A. B. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00873.x · Cited by 560 · cited 3×
“Toxin-induced demyelination following lysolecithin injection into the spinal cord or corpus callosum, or ethidium bromide injection into the cerebellar peduncles results in minimal immune response and robust remyelination (Back et al., 2005; Franklin et al., 1991, 1996; Harrington et al., 2010; Kotter et al., 2001; Na…”
Cited by
Myelination of the Nervous System: Mechanisms and Functions
Nave, K.-A., & Werner, H. B. (2014) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-100913-013101 · Cited by 983
van der Knaap, M. S., & Bugiani, M. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1739-1 · Cited by 403
“Astrocytes also secrete ECM components and are involved in ECM remodeling, which may affect OPC proliferation, differentiation and myelination [9, 87].”
BackgroundCell adhesion and matricellular support by astrocytes of the tripartite synapse
Hillen, A. E. J., Burbach, J. P. H., & Hol, E. M. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.02.002 · Cited by 108
Premyelinating Oligodendrocytes: Mechanisms Underlying Cell Survival and Integration
Hughes, E. G., & Stockton, M. E. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.714169 · Cited by 98
Hou, J., Zhou, Y., Cai, Z., Terekhova, M., Swain, A., Andhey, P. S., Guimaraes, R. M., Ulezko Antonova, A., Qiu, T., Sviben, S., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112293 · Cited by 85
Metadata
- Authors
- Harlow, D. E., & Macklin, W. B.
- Venue
- Experimental Neurology
- Publisher
- Elsevier BV
- Published
- 2014-01
- Volume
- 251
- Pages
- 39-46
- ISSN
- 0014-4886 (ISSN-L)
- OpenAlex
- W2075480738
- Cited by
- 78
- References
- 31
- FWCI
- 4.45
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inhibitors of myelination: ECM changes, CSPGs and PTPs. https://app.cochat.ai/papers/10.1016/j.expneurol.2013.10.017
- The paper
- Harlow, D. E., & Macklin, W. B. (2014). Inhibitors of myelination: ECM changes, CSPGs and PTPs. Experimental Neurology. https://doi.org/10.1016/j.expneurol.2013.10.017
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.